nodes	percent_of_prediction	percent_of_DWPC	metapath
Desflurane—Metabolic acidosis—Teniposide—lymphatic system cancer	0.034	0.034	CcSEcCtD
Desflurane—Metabolic acidosis—Fludarabine—lymphatic system cancer	0.0299	0.0299	CcSEcCtD
Desflurane—Blindness transient—Methotrexate—lymphatic system cancer	0.0192	0.0192	CcSEcCtD
Desflurane—Cyanosis—Teniposide—lymphatic system cancer	0.019	0.019	CcSEcCtD
Desflurane—Hypoxia—Fludarabine—lymphatic system cancer	0.0186	0.0186	CcSEcCtD
Desflurane—Respiratory distress—Fludarabine—lymphatic system cancer	0.0186	0.0186	CcSEcCtD
Desflurane—Haemoptysis—Fludarabine—lymphatic system cancer	0.016	0.016	CcSEcCtD
Desflurane—Transaminases increased—Carmustine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Desflurane—Respiratory failure—Fludarabine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Desflurane—Encephalopathy—Carmustine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Desflurane—Hyperkalaemia—Fludarabine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Desflurane—Respiratory distress—Vincristine—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Desflurane—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Desflurane—Electrocardiogram abnormal—Mitoxantrone—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Desflurane—Jaundice—Mechlorethamine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Desflurane—Hepatic failure—Fludarabine—lymphatic system cancer	0.00955	0.00955	CcSEcCtD
Desflurane—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00921	0.00921	CcSEcCtD
Desflurane—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00917	0.00917	CcSEcCtD
Desflurane—Liver function test abnormal—Teniposide—lymphatic system cancer	0.00902	0.00902	CcSEcCtD
Desflurane—Myocardial ischaemia—Mitoxantrone—lymphatic system cancer	0.00875	0.00875	CcSEcCtD
Desflurane—Bronchospasm—Teniposide—lymphatic system cancer	0.0083	0.0083	CcSEcCtD
Desflurane—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00793	0.00793	CcSEcCtD
Desflurane—Blood bilirubin increased—Mitoxantrone—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Desflurane—Respiratory failure—Vincristine—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Desflurane—Hyperkalaemia—Mitoxantrone—lymphatic system cancer	0.00691	0.00691	CcSEcCtD
Desflurane—Haemoglobin—Teniposide—lymphatic system cancer	0.00679	0.00679	CcSEcCtD
Desflurane—Haemorrhage—Teniposide—lymphatic system cancer	0.00676	0.00676	CcSEcCtD
Desflurane—Acute coronary syndrome—Fludarabine—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Desflurane—Renal failure—Fludarabine—lymphatic system cancer	0.0065	0.0065	CcSEcCtD
Desflurane—Myocardial infarction—Fludarabine—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Desflurane—Infection—Mechlorethamine—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Desflurane—Eye pain—Carmustine—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Desflurane—Arrhythmia—Teniposide—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Desflurane—Haemoglobin—Fludarabine—lymphatic system cancer	0.00597	0.00597	CcSEcCtD
Desflurane—Haemorrhage—Fludarabine—lymphatic system cancer	0.00594	0.00594	CcSEcCtD
Desflurane—Pharyngitis—Fludarabine—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Desflurane—Hepatic failure—Vincristine—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Desflurane—Hypoxia—Methotrexate—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Desflurane—Encephalopathy—Methotrexate—lymphatic system cancer	0.00546	0.00546	CcSEcCtD
Desflurane—Agitation—Teniposide—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Desflurane—Bronchospasm—Bleomycin—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Desflurane—Arrhythmia—Fludarabine—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Desflurane—Malnutrition—Fludarabine—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Desflurane—Liver disorder—Methotrexate—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Desflurane—Hypertension—Teniposide—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Desflurane—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Desflurane—Hypokalaemia—Carmustine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Desflurane—Cardiac arrest—Vincristine—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Desflurane—Cyanosis—Methotrexate—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Desflurane—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Desflurane—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Desflurane—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Desflurane—Infection—Teniposide—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Desflurane—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Desflurane—Agitation—Fludarabine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Desflurane—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Desflurane—Tachycardia—Teniposide—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Desflurane—Malaise—Fludarabine—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Desflurane—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Desflurane—Pruritus—Mechlorethamine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Desflurane—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Desflurane—Cough—Fludarabine—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Desflurane—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Desflurane—Hypotension—Teniposide—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Desflurane—Convulsion—Fludarabine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Desflurane—Myalgia—Fludarabine—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Desflurane—Haemoglobin—Bleomycin—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Desflurane—Haemorrhage—Bleomycin—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Desflurane—Discomfort—Fludarabine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Desflurane—Dyspnoea—Teniposide—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Desflurane—Infection—Fludarabine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Desflurane—Renal failure—Carmustine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Desflurane—Vomiting—Mechlorethamine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Desflurane—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Desflurane—Apnoea—Methotrexate—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Desflurane—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Desflurane—Myocardial infarction—Vincristine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Desflurane—Feeling abnormal—Teniposide—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Desflurane—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Desflurane—Bone disorder—Methotrexate—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Desflurane—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Desflurane—Renal failure—Mitoxantrone—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Desflurane—Nausea—Mechlorethamine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Desflurane—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Desflurane—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Desflurane—Jaundice—Mitoxantrone—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Desflurane—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Desflurane—Haemoglobin—Carmustine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Desflurane—Urticaria—Teniposide—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Desflurane—Haemorrhage—Carmustine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Desflurane—Abdominal pain—Teniposide—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Desflurane—Body temperature increased—Teniposide—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Desflurane—Erythema—Bleomycin—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Desflurane—Dyspnoea—Fludarabine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Desflurane—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Desflurane—Fatigue—Fludarabine—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Desflurane—Bradycardia—Mitoxantrone—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Desflurane—Respiratory failure—Methotrexate—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Desflurane—Eye disorder—Carmustine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Desflurane—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Desflurane—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Desflurane—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Desflurane—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Desflurane—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Desflurane—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Desflurane—Asthenia—Teniposide—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Desflurane—Malaise—Bleomycin—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Desflurane—Pruritus—Teniposide—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Desflurane—Arrhythmia—Carmustine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Desflurane—Cardiac disorder—Vincristine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Desflurane—Body temperature increased—Fludarabine—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Desflurane—Mental disorder—Carmustine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Desflurane—Erythema—Carmustine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Desflurane—Malnutrition—Carmustine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Desflurane—Cough—Bleomycin—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Desflurane—Angiopathy—Vincristine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Desflurane—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Desflurane—Myalgia—Bleomycin—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Desflurane—Discomfort—Bleomycin—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Desflurane—Mental disorder—Vincristine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Desflurane—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Desflurane—Erythema—Mitoxantrone—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Desflurane—Infection—Bleomycin—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Desflurane—Vomiting—Teniposide—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Desflurane—Agitation—Carmustine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Desflurane—Asthenia—Fludarabine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Desflurane—Headache—Teniposide—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Desflurane—Pruritus—Fludarabine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Desflurane—Agitation—Vincristine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Desflurane—Hypotension—Bleomycin—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Desflurane—Convulsion—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Desflurane—Hypertension—Carmustine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Desflurane—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Desflurane—Nausea—Teniposide—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Desflurane—Hepatic failure—Methotrexate—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Desflurane—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Desflurane—Myalgia—Carmustine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Desflurane—Malaise—Mitoxantrone—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Desflurane—Dyspnoea—Bleomycin—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Desflurane—Convulsion—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Desflurane—Hypertension—Vincristine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Desflurane—Myalgia—Vincristine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Desflurane—Cough—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Desflurane—Infection—Carmustine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Desflurane—Vomiting—Fludarabine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Desflurane—Convulsion—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Desflurane—Hypertension—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Desflurane—Headache—Fludarabine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Desflurane—Tachycardia—Carmustine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Desflurane—Myalgia—Mitoxantrone—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Desflurane—Discomfort—Mitoxantrone—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Desflurane—Infection—Vincristine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Desflurane—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Desflurane—Nervous system disorder—Vincristine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Desflurane—Hypotension—Carmustine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Desflurane—Nausea—Fludarabine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Desflurane—Infection—Mitoxantrone—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Desflurane—Shock—Mitoxantrone—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Desflurane—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Desflurane—Urticaria—Bleomycin—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Desflurane—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Desflurane—Body temperature increased—Bleomycin—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Desflurane—Hypotension—Vincristine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Desflurane—Dyspnoea—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Desflurane—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Desflurane—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Desflurane—Hypotension—Mitoxantrone—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Desflurane—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Desflurane—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Desflurane—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Desflurane—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Desflurane—Feeling abnormal—Carmustine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Desflurane—Fatigue—Vincristine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Desflurane—Asthenia—Bleomycin—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Desflurane—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Desflurane—Asthma—Methotrexate—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Desflurane—Pruritus—Bleomycin—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Desflurane—Fatigue—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Desflurane—Body temperature increased—Carmustine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Desflurane—Abdominal pain—Carmustine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Desflurane—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Desflurane—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Desflurane—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Desflurane—Abdominal pain—Vincristine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Desflurane—Body temperature increased—Vincristine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Desflurane—Urticaria—Mitoxantrone—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Desflurane—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Desflurane—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Desflurane—Vomiting—Bleomycin—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Desflurane—Infestation NOS—Methotrexate—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Desflurane—Infestation—Methotrexate—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Desflurane—Asthenia—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Desflurane—Renal failure—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Desflurane—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Desflurane—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Desflurane—Asthenia—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Desflurane—Nausea—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Desflurane—Asthenia—Mitoxantrone—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Desflurane—Dizziness—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Desflurane—Haemoglobin—Methotrexate—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Desflurane—Haemorrhage—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Desflurane—Hepatitis—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Desflurane—Pharyngitis—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Desflurane—Vomiting—Carmustine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Desflurane—Dizziness—Vincristine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Desflurane—Headache—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Desflurane—Eye disorder—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Desflurane—Vomiting—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Desflurane—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Desflurane—Headache—Vincristine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Desflurane—Nausea—Carmustine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Desflurane—Angiopathy—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Desflurane—Vomiting—Mitoxantrone—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Desflurane—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Desflurane—Headache—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Desflurane—Mental disorder—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Desflurane—Erythema—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Desflurane—Malnutrition—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Desflurane—Nausea—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Desflurane—Nausea—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Desflurane—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Desflurane—Malaise—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Desflurane—Cough—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Desflurane—Convulsion—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Desflurane—Myalgia—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Desflurane—Discomfort—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Desflurane—Infection—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Desflurane—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Desflurane—Hypotension—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Desflurane—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Desflurane—Dyspnoea—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Desflurane—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Desflurane—Fatigue—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Desflurane—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Desflurane—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Desflurane—Urticaria—Methotrexate—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Desflurane—Body temperature increased—Methotrexate—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Desflurane—Abdominal pain—Methotrexate—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Desflurane—Asthenia—Methotrexate—lymphatic system cancer	0.000897	0.000897	CcSEcCtD
Desflurane—Pruritus—Methotrexate—lymphatic system cancer	0.000885	0.000885	CcSEcCtD
Desflurane—Dizziness—Methotrexate—lymphatic system cancer	0.000827	0.000827	CcSEcCtD
Desflurane—Vomiting—Methotrexate—lymphatic system cancer	0.000795	0.000795	CcSEcCtD
Desflurane—Headache—Methotrexate—lymphatic system cancer	0.000784	0.000784	CcSEcCtD
Desflurane—Nausea—Methotrexate—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
